13721-01-2 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
4 4-DIMETHYLCYCLOHEXANONE 97 Basic information 4...
344-14-9 Dimethyl Fluoromalonate
Dimethyl fluoromalonate Basic information Dimethyl...
3674-09-7 Methyl 2,3-dichloropropionate
Methyl 2,3-dichloropropionate Basic information Methyl...
FDA Drug Shortages
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
School Kids Need Supervision After Classes End
SUNDAY, Aug. 26, 2018 -- As parents send their kids back to school, they need to remember the school day includes the hours before and after classes, a leading pediatrician's group says.
World Health Organization Recommends The Use Of Bedaquili...
Beerse, Belgium, August 17, 2018 – Johnson & Johnson today acknowledges the issuance of a “Rapid Communication” by the World Health Organization (WHO) describing key changes to treatment guidelines for multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). The document describes a regrouping and ranking of MDR-TB drugs based on the latest evidence about the balance of effectiveness to safety. The oral medicine bedaquiline (SIRTURO®) is now categorized as a “Group A” medicine to be prioritized when constructing a conventional (long-course) regimen for the treatment of MDR-TB as part of combination therapy in adults and children.
Catch-Up HPV Doses Effective To Age 21 Against Cervical N...
WEDNESDAY, Aug. 22, 2018 -- Catch-up doses of quadrivalent human papillomavirus (HPV) vaccination are effective for girls and women aged 14 to 20 years at the time of first dose, according to a study published online Aug. 7 in The Lancet Child & Adolescent Health.